Xvivo Perfusion AB (publ) (LON: 0RKL)
London
· Delayed Price · Currency is GBP · Price in SEK
429.50
+9.72 (2.32%)
Jan 23, 2025, 1:44 PM BST
Xvivo Perfusion AB Employees
Xvivo Perfusion AB had 160 employees as of December 30, 2023. The number of employees increased by 20 or 14.29% compared to the previous year.
Employees
160
Change (1Y)
20
Growth (1Y)
14.29%
Revenue / Employee
342.95K GBP
Profits / Employee
93.33K GBP
Market Cap
968.17M
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 30, 2023 | 160 | 20 | 14.29% |
Dec 30, 2022 | 140 | 27 | 23.89% |
Dec 30, 2021 | 113 | 31 | 37.80% |
Dec 30, 2020 | 82 | 42 | 105.00% |
Dec 30, 2018 | 40 | - | - |
Related Stocks
Company Name | Employees |
---|---|
AstraZeneca | 89,900 |
GSK plc | 70,212 |
Haleon | 25,408 |
Smith & Nephew | 18,452 |
ConvaTec Group | 10,136 |
Hikma Pharmaceuticals | 9,100 |
HUTCHMED (China) | 1,988 |
Oxford Nanopore Technologies | 1,238 |